MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 37 filers reported holding MEI PHARMA INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $1,056,000 | +107.1% | 600,000 | +84.6% | 0.19% | -6.5% |
| Q3 2015 | $510,000 | +19.2% | 325,000 | +30.0% | 0.20% | +48.9% |
| Q2 2015 | $428,000 | +59.1% | 250,000 | +66.7% | 0.14% | +19.5% |
| Q1 2015 | $269,000 | -82.0% | 150,000 | -57.1% | 0.11% | -84.3% |
| Q4 2014 | $1,495,000 | – | 350,000 | – | 0.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TLS Advisors LLC | 2,010,285 | $490 | 2.42% |
| Anson Funds Management LP | 10,617,959 | $2,586,535 | 0.43% |
| NEA Management Company, LLC | 8,533,072 | $2,078,656 | 0.12% |
| Boxer Capital, LLC | 2,913,091 | $709,629 | 0.04% |
| Investmark Advisory Group LLC | 136,000 | $33,130 | 0.02% |
| CARLSON CAPITAL L P | 1,180,000 | $287,448 | 0.02% |
| Mesirow Financial Investment Management, Inc. | 20,486 | $4,990 | 0.02% |
| Artal Group S.A. | 1,000,000 | $244 | 0.01% |
| Annandale Capital, LLC | 100,000 | $24 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 4,758,364 | $1,158 | 0.01% |